ClinicalTrials.Veeva

Menu

Urinary Sensor for Cystourethrography

R

Rambam Health Care Campus

Status

Completed

Conditions

Radiation Dose During VCUG

Treatments

Other: placebo
Device: Urinary sensor

Study type

Interventional

Funder types

Other

Identifiers

NCT00547820
OBrook2518CTIL

Details and patient eligibility

About

Evaluation of urinary sensor that will be activated by the urine during voiding cystourethrography in pediatric patients

Full description

It is of immense importance to perform fluoroscopy during voiding phase of VCUG (Voiding Cystourethrogram) procedures in order to rule out vesicourethral reflux. It is difficult to know exactly when a child will start voiding, so the child is intermittently imaged by fluoroscopy. Fluoroscopy involves radiation, and this we try to diminish as much as possible. We suggest application of small urinary sensor in the perineum of the patient, that will signal the beginning of urination, and only then fluoroscopy will begin. This urinary sensor should cut down substantially radiation dose to the patient.

Enrollment

20 estimated patients

Sex

All

Ages

1 month to 10 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • children referred for VCUG procedure at out department

Exclusion criteria

  • children with pacemakers
  • decline to participate

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

20 participants in 2 patient groups, including a placebo group

A
Experimental group
Description:
with application of urinary sensor
Treatment:
Device: Urinary sensor
B
Placebo Comparator group
Description:
without use of urinary sensor
Treatment:
Other: placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems